Update on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?

With Nikolaus Marx, Chair of Task Force of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes, RWTH University Hospital Aachen, Aachen - Germany and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.

In this podcast, Nikolaus Marx joins Ruxandra Christodorescu to discuss updates on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?